EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 15 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,000 | -50.0% | 466 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 466 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 466 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 466 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 466 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 466 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 466 | +39.9% | 0.00% | – |
Q4 2019 | $3,000 | +200.0% | 333 | -2.6% | 0.00% | – |
Q3 2019 | $1,000 | – | 342 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,815,500 | $8,950,000 | 0.30% |
Sterling Financial Planning, Inc. | 1,171 | $6,000 | 0.01% |
UBS Group AG | 3,991 | $20,000 | 0.00% |
OSAIC HOLDINGS, INC. | 468 | $2,000 | 0.00% |
US BANCORP \DE\ | 2,710 | $13,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 34 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 12,656 | $62,000 | 0.00% |
North Star Investment Management Corp. | 20 | $0 | 0.00% |
MORGAN STANLEY | 466 | $2,000 | 0.00% |